Low Seroprevalence among Undetected COVID-19 Cases, Faroe Islands, November 2020
SARS
SARS-CoV-2
Denmark
R
COVID-19
Infectious and parasitic diseases
RC109-216
Antibodies, Viral
3. Good health
respiratory infections
03 medical and health sciences
0302 clinical medicine
coronavirus disease
Seroepidemiologic Studies
Research Letter
Prevalence
Medicine
Humans
severe acute respiratory syndrome coronavirus 2
DOI:
10.3201/eid2801.210917
Publication Date:
2021-11-10T14:29:14Z
AUTHORS (10)
ABSTRACT
We conducted a second nationwide severe acute respiratory syndrome coronavirus 2 seroprevalence study in the Faroe Islands during November 2020. We found crude seroprevalence was 0.3% and prevalence was 0.4% after adjusting for test sensitivity and specificity. This low seroprevalence supports the prevention strategies used in the Faroe Islands.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (10)
CITATIONS (4)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....